4.10.1Segment

Allergy & Immunology

Allergy and clinical immunology practices providing testing, immunotherapy, and asthma management services.

5
Verticals

Overview

Allergy & Immunology practices provide testing, immunotherapy, and asthma-management services. Immunotherapy (allergy shots and increasingly biologics) provides recurring, in-office revenue that supports attractive practice economics and emerging consolidation.

Demand is supported by rising allergy and asthma prevalence and the growth of biologic therapies for severe allergic and respiratory conditions. It is a fragmented specialty seeing early MSO and PE roll-up interest.

Market snapshot

FragmentationConsolidating

Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so allergy and immunology is not separately sized.

Business model & economics

Revenue model
Testing, immunotherapy, and biologic-infusion reimbursement
Recurring revenue
High — recurring immunotherapy visits
EBITDA margin
18–28%
Capex intensity
Low
  • Recurring in-office immunotherapy revenue.
  • Rising allergy/asthma prevalence and biologics.
  • Early MSO and PE roll-up interest.

M&A deal context

Moderate deal activity

Who’s acquiring

Emerging allergy MSO platformsPE-backed consolidatorsMultispecialty acquirers

What’s driving deals

  • Emerging allergy roll-up.
  • Allergy/asthma and biologics demand.
  • Recurring immunotherapy economics.

Verticals in this segment

  • 4.10.1.1Allergy & Immunotherapy Practices

    Allergists providing testing, SCIT, and SLIT immunotherapy.

  • 4.10.1.2Allergy Management Organizations

    PE-backed platforms consolidating allergy and immunology practices.

  • 4.10.1.3Asthma & Pulmonary Allergy Programs

    Practices managing asthma and pulmonary allergy conditions.

  • 4.10.1.4Clinical Immunology Centers

    Physicians treating primary and secondary immune system disorders.

  • 4.10.1.5Food Allergy Specialty Clinics

    Clinics providing oral immunotherapy for food allergy desensitization.

Find Allergy & Immunology acquisition targets

Search Acquisera’s index for companies classified under Allergy & Immunology (4.10.1) and build a targeted deal pipeline.

Search companies